Investors & Media

Dec 11, 2018 5:14 PM EST

Copyright Nasdaq. Minimum 15 minutes delayed.

Investors & Media

SEC Filing Details

SEC Filing Details

Document Details

Form
Filing Date
Feb 16, 2018
Document Date
Feb 15, 2018
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Keryx Biopharmaceuticals, Inc.
Issuer
KERYX BIOPHARMACEUTICALS INC
Filer
Neylan John F.